Isis Pharmaceuticals Inc insider trades: Akcea Therapeutics (AKCA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Isis Pharmaceuticals Inc reports to the SEC
Open-market buys and sales
25 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 10, 2020 | AKCA | ↑ Buy | 21,237,715 | $18.15 | $385.5M | Indirect | Oct 14, 2020 (4d) |
| Apr 17, 2018 | AKCA | ↑ Buy | 10,666,666 | $18.75 | $200.0M | Direct | Apr 19, 2018 (2d) |
| Jul 19, 2017 | AKCA | ↑ Buy | 3,125,000 | $8.00 | $25.0M | Direct | Jul 21, 2017 (2d) |
| Jul 17, 2015 | RGLS | ↓ Sell | 343,133 | $10.60 | $3.6M | Direct | Jul 17, 2015 (0d) |
| Jun 30, 2015 | RGLS | ↓ Sell | 13,248 | $10.79 | $143K | Direct | Jul 2, 2015 (2d) |
| Nov 3, 2014 | RGLS | ↓ Sell | 1,279,411 | $15.94 | $20.4M | Direct | Nov 5, 2014 (2d) |
| Oct 24, 2014 | RGLS | ↓ Sell | 113,084 | $14.02 | $1.6M | Direct | Oct 24, 2014 (0d) |
| Oct 17, 2014 | RGLS | ↓ Sell | 12,100 | $6.74 | $82K | Direct | Oct 17, 2014 (0d) |
| Oct 10, 2014 | RGLS | ↓ Sell | 10,050 | $6.56 | $66K | Direct | Oct 10, 2014 (0d) |
| Oct 3, 2014 | RGLS | ↓ Sell | 10,300 | $6.74 | $69K | Direct | Oct 3, 2014 (0d) |
| Sep 26, 2014 | RGLS | ↓ Sell | 8,750 | $7.13 | $62K | Direct | Sep 26, 2014 (0d) |
| Sep 19, 2014 | RGLS | ↓ Sell | 7,700 | $7.31 | $56K | Direct | Sep 19, 2014 (0d) |
| Sep 12, 2014 | RGLS | ↓ Sell | 8,900 | $7.85 | $70K | Direct | Sep 12, 2014 (0d) |
| Sep 5, 2014 | RGLS | ↓ Sell | 10,050 | $7.07 | $71K | Direct | Sep 5, 2014 (0d) |
| Aug 29, 2014 | "RGLS" | ↓ Sell | 5,000 | $7.00 | $35K | Direct | Aug 29, 2014 (0d) |
| Aug 22, 2014 | "RGLS" | ↓ Sell | 10,750 | $6.89 | $74K | Direct | Aug 22, 2014 (0d) |
| Aug 15, 2014 | "RGLS" | ↓ Sell | 5,450 | $7.01 | $38K | Direct | Aug 15, 2014 (0d) |
| Aug 8, 2014 | "RGLS" | ↓ Sell | 7,600 | $6.87 | $52K | Direct | Aug 8, 2014 (0d) |
| Aug 1, 2014 | "RGLS" | ↓ Sell | 5,350 | $6.35 | $34K | Direct | Aug 1, 2014 (0d) |
| Jul 25, 2014 | "RGLS" | ↓ Sell | 5,250 | $6.75 | $35K | Direct | Jul 25, 2014 (0d) |
| Jul 18, 2014 | "RGLS" | ↓ Sell | 13,500 | $6.66 | $90K | Direct | Jul 18, 2014 (0d) |
| Jul 11, 2014 | "RGLS" | ↓ Sell | 8,050 | $6.73 | $54K | Direct | Jul 11, 2014 (0d) |
| Jul 3, 2014 | "RGLS" | ↓ Sell | 4,300 | $8.07 | $35K | Direct | Jul 7, 2014 (4d) |
| Jun 27, 2014 | "RGLS" | ↓ Sell | 7,600 | $7.88 | $60K | Direct | Jun 27, 2014 (0d) |
| Oct 10, 2012 | RGLS | ↑ Buy | 750,000 | $4.00 | $3.0M | Direct | Oct 11, 2012 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Isis Pharmaceuticals Inc's insider trades
Isis Pharmaceuticals Inc is a 10% owner of Akcea Therapeutics (AKCA). Since Oct 10, 2012, it has reported 4 open-market purchases worth $613.5M and 21 sales worth $26.7M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include other transactions (6 filings), conversions (2 filings), gifts (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AKCA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.